AAAAAA

   
Results: 1-22 |
Results: 22
Cancer chemotherapy: A paclitaxel prodrug for ADEPT (antibody-directed enzyme prodrug therapy)
Authors: Schmidt, F Ungureanu, I Duval, R Pompon, A Monneret, C
Citation: F. Schmidt et al., Cancer chemotherapy: A paclitaxel prodrug for ADEPT (antibody-directed enzyme prodrug therapy), EUR J ORG C, (11), 2001, pp. 2129-2134
A new acivicin prodrug designed for tumor-targeted delivery
Authors: Antczak, C Bauvois, B Monneret, C Florent, JC
Citation: C. Antczak et al., A new acivicin prodrug designed for tumor-targeted delivery, BIO MED CH, 9(11), 2001, pp. 2843-2848
Recent developments in the field of antitumour anthracyclines
Authors: Monneret, C
Citation: C. Monneret, Recent developments in the field of antitumour anthracyclines, EUR J MED C, 36(6), 2001, pp. 483-493
Targeting of acivicin prodrugs as antibody conjugates
Authors: Antczak, C Bauvois, B Monneret, C Florent, JC
Citation: C. Antczak et al., Targeting of acivicin prodrugs as antibody conjugates, J CONTR REL, 74(1-3), 2001, pp. 255-257
Synthesis of bis-heteroaryl piperazine derivatives as potential reverse transcriptase inhibitors
Authors: Guillaumel, J Grierson, DS Monneret, C
Citation: J. Guillaumel et al., Synthesis of bis-heteroaryl piperazine derivatives as potential reverse transcriptase inhibitors, J HETERO CH, 38(4), 2001, pp. 985-988
2-nitro and 4-nitro-quinone-methides are not irreversible inhibitors of bovine beta-glucuronidase
Authors: Azoulay, M Chalard, F Gesson, JP Florent, JC Monneret, C
Citation: M. Azoulay et al., 2-nitro and 4-nitro-quinone-methides are not irreversible inhibitors of bovine beta-glucuronidase, CARBOHY RES, 332(2), 2001, pp. 151-156
Direct in vivo observation of 5-fluorouracil release from a prodrug in human tumors heterotransplanted in nude mice: a magnetic resonance study
Authors: Guerquin-Kern, JL Volk, A Chenu, E Lougerstay-Madec, R Monneret, C Florent, JC Carrez, D Croisy, A
Citation: Jl. Guerquin-kern et al., Direct in vivo observation of 5-fluorouracil release from a prodrug in human tumors heterotransplanted in nude mice: a magnetic resonance study, NMR BIOMED, 13(5), 2000, pp. 306
Synthesis of a novel sialyl Lewis X analogue containing a pyrrolidine in place of N-acetyl glucosamine
Authors: Dechaux, E Savy, P Bouyain, S Monneret, C Florent, JC
Citation: E. Dechaux et al., Synthesis of a novel sialyl Lewis X analogue containing a pyrrolidine in place of N-acetyl glucosamine, J CARB CHEM, 19(4-5), 2000, pp. 485-501
Design of two etoposide-amsacrine conjugates: topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity
Authors: Arimondo, P Boukarim, C Bailly, C Dauzonne, D Monneret, C
Citation: P. Arimondo et al., Design of two etoposide-amsacrine conjugates: topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity, ANTI-CAN DR, 15(6), 2000, pp. 413-421
Synthesis and antitumour activity of a new series of nitrosoureido sugars
Authors: Monneret, C Risse, S Ardouin, P Gouyette, A
Citation: C. Monneret et al., Synthesis and antitumour activity of a new series of nitrosoureido sugars, EUR J MED C, 35(1), 2000, pp. 137-146
Synthesis of picropodophyllin homolactone
Authors: Roulland, E Bertounesque, E Huel, C Monneret, C
Citation: E. Roulland et al., Synthesis of picropodophyllin homolactone, TETRAHEDR L, 41(35), 2000, pp. 6769-6773
Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase
Authors: Pontikis, R Dolle, V Guillaumel, J Dechaux, E Note, R Nguyen, CH Legraverend, M Bisagni, E Aubertin, AM Grierson, DS Monneret, C
Citation: R. Pontikis et al., Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase, J MED CHEM, 43(10), 2000, pp. 1927-1939
Immunotargeting of antitumor drugs
Authors: Monneret, C Florent, JC
Citation: C. Monneret et Jc. Florent, Immunotargeting of antitumor drugs, B CANCER, 87(11), 2000, pp. 829-838
Prodrugs of natural anthracyclines suited for Antibody Directed Enzyme Prodrug Therapy (ADEPT) and prodrug monotherapy (PMT)
Authors: Michel, S Desbene, S Gesson, JP Monneret, C Tillequin, F
Citation: S. Michel et al., Prodrugs of natural anthracyclines suited for Antibody Directed Enzyme Prodrug Therapy (ADEPT) and prodrug monotherapy (PMT), ST NAT PROD, 21, 2000, pp. 157-180
"Mixed inhibitors" of HIV-reverse transcriptase: Synthesis and antiviral activity
Authors: Pontikis, R Note, R Dechaux, E Guillaumel, J Aubertin, AM Grierson, DS Monneret, C
Citation: R. Pontikis et al., "Mixed inhibitors" of HIV-reverse transcriptase: Synthesis and antiviral activity, NUCLEOS NUC, 18(4-5), 1999, pp. 707-708
Efficient synthesis of N-4 alkyl derivatives of 2 ',3 '-dideoxycytidine (ddC).
Authors: Dechaux, E Pontikis, R Monneret, C
Citation: E. Dechaux et al., Efficient synthesis of N-4 alkyl derivatives of 2 ',3 '-dideoxycytidine (ddC)., NUCLEOS NUC, 18(1), 1999, pp. 1-4
Synthesis of self-immolative glucuronide spacers based on aminomethylcarbamate. Application to 5-fluorouracil prodrugs for antibody-directed enzyme prodrug therapy
Authors: Madec-Lougerstay, R Florent, JC Monneret, C
Citation: R. Madec-lougerstay et al., Synthesis of self-immolative glucuronide spacers based on aminomethylcarbamate. Application to 5-fluorouracil prodrugs for antibody-directed enzyme prodrug therapy, J CHEM S P1, (10), 1999, pp. 1369-1375
Application of the ADEPT strategy to the MDR resistance in cancer chemotherapy
Authors: Desbene, S Van, HDT Michel, S Tillequin, F Koch, M Schmidt, F Florent, JC Monneret, C Straub, R Czech, J Gerken, M Bosslet, K
Citation: S. Desbene et al., Application of the ADEPT strategy to the MDR resistance in cancer chemotherapy, ANTI-CAN DR, 14(2), 1999, pp. 93-106
Synthetic approaches to condensed aromatic analogues from etoposide, synthesis of A-ring pyridazine picroetoposide
Authors: Meresse, P Bertounesque, E Imbert, T Monneret, C
Citation: P. Meresse et al., Synthetic approaches to condensed aromatic analogues from etoposide, synthesis of A-ring pyridazine picroetoposide, TETRAHEDRON, 55(44), 1999, pp. 12805-12818
Synthesis and biological evaluation of 5-arylfuro[2,3-d]pyrimidines as novel dihydrofolate reductase inhibitors
Authors: Wahid, F Monneret, C Dauzonne, D
Citation: F. Wahid et al., Synthesis and biological evaluation of 5-arylfuro[2,3-d]pyrimidines as novel dihydrofolate reductase inhibitors, CHEM PHARM, 47(2), 1999, pp. 156-164
Doxorubicin prodrugs with reduced cytotoxicity suited for tumour-specific activation
Authors: Desbene, S Van, HDT Michel, S Koch, M Tillequin, F Fournier, G Farjaudon, N Monneret, C
Citation: S. Desbene et al., Doxorubicin prodrugs with reduced cytotoxicity suited for tumour-specific activation, ANTI-CAN DR, 13(8), 1998, pp. 955-968
Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustard
Authors: Lougerstay-Madec, R Florent, JC Monneret, C Nemati, F Poupon, MF
Citation: R. Lougerstay-madec et al., Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustard, ANTI-CAN DR, 13(8), 1998, pp. 995-1007
Risultati: 1-22 |